• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

Comprehensive Overview of rac-tert-butyl N-{1-(1R,3S)-3-amino-2,2-dimethylcyclopropylcyclohexyl}carbamate (CAS No. 2227729-28-2)

The compound rac-tert-butyl N-{1-(1R,3S)-3-amino-2,2-dimethylcyclopropylcyclohexyl}carbamate (CAS No. 2227729-28-2) is a chiral carbamate derivative with significant potential in pharmaceutical and agrochemical research. Its unique structural features, including the cyclopropyl and cyclohexyl moieties, make it a valuable intermediate for synthesizing bioactive molecules. Researchers are increasingly interested in this compound due to its stereochemical complexity and potential applications in drug discovery, particularly in targeting G-protein-coupled receptors (GPCRs) and enzyme inhibitors.

In recent years, the demand for chiral building blocks like rac-tert-butyl N-{1-(1R,3S)-3-amino-2,2-dimethylcyclopropylcyclohexyl}carbamate has surged, driven by advancements in asymmetric synthesis and medicinal chemistry. This compound's tert-butyl carbamate group enhances its stability, making it suitable for multi-step synthetic routes. Its amino-functionalized cyclopropane ring is particularly noteworthy, as cyclopropane derivatives are known for their conformational rigidity and bioactivity, often explored in central nervous system (CNS) drug development.

From an industrial perspective, CAS No. 2227729-28-2 is gaining attention for its scalability in green chemistry processes. With growing emphasis on sustainable synthesis, researchers are optimizing catalytic methods to produce this compound with minimal waste. Questions like "How to synthesize rac-tert-butyl N-{1-(1R,3S)-3-amino-2,2-dimethylcyclopropylcyclohexyl}carbamate efficiently?" or "What are the applications of chiral cyclopropane derivatives?" are frequently searched, reflecting the compound's relevance in modern organic chemistry.

The stereochemistry of rac-tert-butyl N-{1-(1R,3S)-3-amino-2,2-dimethylcyclopropylcyclohexyl}carbamate is critical for its biological interactions. The (1R,3S) configuration influences its binding affinity to biological targets, a topic often discussed in computational chemistry forums. Additionally, its cyclohexyl component contributes to lipophilicity, a key factor in drug permeability studies. These attributes align with current trends in personalized medicine, where molecular precision is paramount.

Analytical techniques such as HPLC, NMR, and mass spectrometry are essential for characterizing CAS No. 2227729-28-2, ensuring purity and enantiomeric excess. The compound's carbamate functionality also makes it a candidate for prodrug design, a hot topic in pharmacokinetics. As the pharmaceutical industry shifts toward targeted therapies, intermediates like this are pivotal for developing next-generation therapeutics.

In summary, rac-tert-butyl N-{1-(1R,3S)-3-amino-2,2-dimethylcyclopropylcyclohexyl}carbamate exemplifies the intersection of structural complexity and functional versatility. Its role in advancing chiral synthesis and drug design underscores its importance in contemporary research, addressing both academic inquiries and industrial challenges.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)